IDENTIFICATION OF RAS FARNESYLTRANSFERASE INHIBITORS BY MICROBIAL SCREENING

被引:253
作者
HARA, M
AKASAKA, K
AKINAGA, S
OKABE, M
NAKANO, H
GOMEZ, R
WOOD, D
UH, M
TAMANOI, F
机构
[1] KYOWA HAKKO KOGYO CO LTD,TOKYO RES LABS,ASAHI MACHI 3-6-6,MACHIDA,TOKYO 194,JAPAN
[2] KYOWA HAKKO KOGYO CO LTD,PHARMACEUT RES LABS,MACHIDA,TOKYO 194,JAPAN
[3] UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,CHICAGO,IL 60637
关键词
GPAL MUTANT; MANUMYCIN; COMPETITIVE INHIBITION; ANTITUMOR ACTIVITY;
D O I
10.1073/pnas.90.6.2281
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A microbial screen using a yeast strain with conditional deficiency in the GPA1 gene was carried out to search for inhibitors of protein farnesyltransferase (PFT). A strain of Streptomyces was found to produce active compounds named UCF1-A, UCF1-B, and UCF1-C. Structural determination of these compounds revealed that UCF1-C is identical to the known antibiotic, manumycin, whereas UCF1-A and UCF1-B are structurally related to manumycin. All three UCF1 compounds suppress the lethality of gpa1 disruption, with UCF1-C exhibiting the strongest activity. UCF1 inhibits yeast as well as rat brain PFT. Fifty percent inhibition of yeast PFT activity is observed with 5 muM UCF1-C. Kinetic analyses of the inhibition suggest that UCF1-C acts as a competitive inhibitor of PFT with respect to farnesyl pyrophosphate, exhibiting a K(i) of 1.2 muM, whereas the same compound appears to act as a noncompetitive inhibitor of PFT with respect to the farnesyl acceptor, the Ras protein. UCF1-C shows significant activity to inhibit the growth of Ki-ras-transformed fibrosarcoma, raising the possibility of its use as an antitumor drug.
引用
收藏
页码:2281 / 2285
页数:5
相关论文
共 33 条